LifeSensors

DUBs, which remove ubiquitin from human proteins, are important targets for drug discovery in a number of therapeutic areas and optimal DUB substrates are essential for these efforts.

Kenneth C. Anderson, MD, Kraft Family Professor of Medicine, Harvard Medical School to Speak at the 4th Ubiquitin Drug Discovery & Diagnostics Conference in Philadelphia

SUMOpro-3, based on the human SUMO-3 protein, is a valuable protein expression platform for expression in E. coli and eukaryotic host systems.

LifeSensors, Inc. announced today that they have appointed Dr. Mark Engleka to the position of Sales and Marketing Director.